SOX11 mutations were reported to occur frequently in the hotspot(D233 del/2_D233 del) in esophageal, gastric and lung cancers, while amplification was the major form of genetic alteration in neuroendocrine prostate cancer (NEPC), OV, PRAD, BRCA and UCEC [48]. This evidence concerns the gene SOX11 and lung carcinoma.